Significant Accounting Policies [Line Items] Significant Accounting Policies [Line Items] Significant accounting policies. Significant Accounting Policies Significant Accounting Policies [Text Block] Statistical Measurement [Domain] Statistical Measurement [Domain] Right to exchange limited common stock to common stock, share Right To Exchange Each Share Of Limited Common Stock To Common Stock Right to exchange each share of limited common stock to common stock. Restricted cash (includes related party amounts of $0 and $72, respectively) Restricted cash Restricted Cash, Current Award Timing Predetermined Award Timing Predetermined [Flag] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Entity File Number Entity File Number Agreement with Gates Ventures, LLC Agreement With Gates Ventures Limited Liability Company [Member] Agreement with Gates Ventures, Limited Liability Company. Additional paid-in capital Additional Paid-in Capital [Member] Tabular List, Table Tabular List [Table Text Block] Recently Issued Accounting Pronouncements and Recently Adopted Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Customer B Customer B [Member] Customer B. Accounts payable Increase (Decrease) in Accounts Payable RSUs and PRSUs Share-Based Payment Arrangement [Member] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Net loss per share of common and limited common stockholders, basic (in USD per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] BMGFT Bill And Melinda Gates Foundation Trust [Member] Bill and Melinda gates foundation trust. Related Party Transactions Related Party Transactions Disclosure [Text Block] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Oncology, Neurology, and Immunology Product Oncology, Neurology, And Immunology Product [Member] Oncology, Neurology, And Immunology Product Revenue Recognition Revenue from Contract with Customer [Text Block] Award Date [Axis] Award Date [Axis] Schedule Of Stock By Class [Table] Stock, Class of Stock [Table] Summary of Financial Information with Respect to Reportable Segments Schedule of Segment Reporting Information, by Segment [Table Text Block] Issuance of common stock upon vesting of RSUs and PRSUs (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Lease liabilities - operating leases Increase (Decrease) In Operating Lease Liabilities Increase decrease in operating lease liabilities. Unsatisfied performance obligation Total remaining performance obligations Revenue, Remaining Performance Obligation, Amount Number of neurology target remaining Contract With Customer, Number Of Neurology Target Remaining Contract With Customer, Number Of Neurology Target Remaining Adjustment to Compensation, Amount Adjustment to Compensation Amount Concentration risk, percentage Concentration Risk, Percentage Percentage of revenue expected to be recognized Revenue, Remaining Performance Obligation, Percentage Number of programs under agreement Collaborative Agreement Number Of Programs Collaborative agreement number of programs. Principles of Consolidation Consolidation, Policy [Policy Text Block] Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Employee Stock Option Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Conversion ratio Preferred Stock, Convertible, Conversion Ratio Limited common stock Limited Common Stock [Member] Limited common stock. Antidilutive Securities Antidilutive Securities [Axis] Total stockholders' equity Beginning balance Ending balance Equity, Attributable to Parent Revenue recognized with milestones Revenue Recognized For Milestone Payment Revenue recognized for milestone payment. Insider Trading Policies and Procedures [Line Items] Total stock-based compensation Share-Based Payment Arrangement, Expense Common stock, shares authorized (in shares) Common Stock, Shares Authorized Segment revenues Segment Reporting Information, Revenue for Reportable Segment [Abstract] Current assets: Assets, Current [Abstract] Total liabilities and stockholders' equity Liabilities and Equity Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Concentration Risk Benchmark Concentration Risk Benchmark [Axis] Concentrations Concentration Risk, Credit Risk, Policy [Policy Text Block] Liabilities and Stockholders' Equity: Liabilities and Equity [Abstract] Cover [Abstract] Cover [Abstract] Cash and cash equivalents and restricted cash Cash and Cash Equivalents, Fair Value Disclosure Maximum Maximum [Member] General and administrative General and Administrative Expense [Member] Schedule Of Equity Method Investments [Table] Equity Method Investment [Table] Novartis Pharma AG Novartis Pharma AG [Member] Novartis Pharma AG Accounting Policies [Abstract] Accounting Policies [Abstract] Summary of Maturities of Operating Lease Liabilities Under Noncancelable Operating Leases Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Concentration Risk Type Concentration Risk Type [Domain] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount February 2023 Award February 2023 Award [Member] February 2023 Award Fair value of RSUs vested during the period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] ADR ADR [Member] Series B Preferred Stock Series B Preferred Stock [Member] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Entity Shell Company Entity Shell Company Other liabilities, long-term Other Liabilities, Noncurrent Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Name Measure Name Gates Ventures, LLC Gates Ventures, LLC [Member] Gates Ventures, LLC Drug discovery contribution Drug Discovery Contribution [Member] Drug Discovery Contribution Software maintenance Maintenance [Member] Summary of Classification of Stock Based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Lease liabilities - operating leases Operating Lease, Liability, Current Total future minimum lease payments Lessee, Operating And Finance Lease, Liability, To Be Paid Lessee, Operating And Finance Lease, Liability, To Be Paid Class Of Stock [Line Items] Class of Stock [Line Items] Document Fiscal Period Focus Document Fiscal Period Focus Number of votes for common share Number Of Votes For Common Share Number of votes for common share. Award Timing Method Award Timing Method [Text Block] Award Type Award Type [Axis] Deferred revenue, long-term Contract with Customer, Liability, Noncurrent Collaboration and License Agreement Collaboration And License Agreement [Member] Collaboration and license agreement. Total assets Assets Investment, Name Investment, Name [Domain] Trading Symbol Trading Symbol Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Geographical Geographical [Domain] Noncash investment accretion Investment Amortization Noncash Expense Investment amortization noncash expense. Income Taxes Income Tax, Policy [Policy Text Block] Entity Address, City or Town Entity Address, City or Town Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Concentration Risk Type Concentration Risk Type [Axis] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Income Statement Location Statement of Income Location, Balance [Domain] Restricted Stock Units Restricted Stock Units (RSUs) [Member] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Assets: Assets, Fair Value Disclosure [Abstract] Number of shares purchased (in shares) Number Of Shares Purchased Number Of Shares Purchased Entity Emerging Growth Company Entity Emerging Growth Company Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Decrease (increase) in assets: Increase (Decrease) in Operating Assets [Abstract] Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Equity investments Equity Method Investments Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] March 2025 Award March 2025 Award [Member] March 2025 Award Maximum percentage of stock options must be granted at exercise price of fair market value (less than) (in percent) Maximum Percentage Of Stock Options Must Be Granted At Exercise Price Of Fair Market Value Maximum percentage of stock options must be granted at exercise price of fair market value. Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Related Party Related Party [Member] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Plan Name [Axis] Plan Name [Axis] Document And Entity Information [Table] Document Information [Table] PEO PEO [Member] Schedule of Revenue Recognized from the Sources of Software Products and Services Revenue Disaggregation of Revenue [Table Text Block] United States UNITED STATES Revenue arrangements, contract term Revenue Arrangements, Contract Term Revenue Arrangements, Contract Term Issuances of common stock upon stock option exercises Stock Issued During Period, Value, Stock Options Exercised Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Expected volatility (in percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Accumulated deficit Retained Earnings [Member] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Share-Based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Cash and cash equivalents and restricted cash, beginning of period Cash and cash equivalents and restricted cash, end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income Statement [Abstract] Income tax expense Income tax expense Income Tax Expense (Benefit) Purchases of marketable securities Payments to Acquire Marketable Securities Tranche Four Share-Based Compensation Award Tranche Four [Member] Share-based compensation award tranche four. Sale of Stock Sale of Stock [Domain] Purchase price (in USD per share) American Depository Shares Purchased, Price Per Share American Depository Shares Purchased, Price Per Share Document And Entity Information [Line Items] Document Information [Line Items] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] March 2024 Award March 2024 Award [Member] March 2024 Award Product and Service [Domain] Product and Service [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Customer Concentration Risk Customer Concentration Risk [Member] Net loss Consolidated net loss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] On-premise software On Premise Software [Member] On premise software. Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Proceeds from issuances of common stock upon stock option exercises Proceeds from Stock Options Exercised City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Schedule of Contract Balances Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] General and administrative (includes related party expense of $165 and $109, respectively) General and administrative General and administrative General and Administrative Expense Unrecognized compensation cost related to unvested stock options granted Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash (used in) provided by operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Software Agreement Software Agreement [Member] Software Agreement Related Party Transactions [Abstract] Related Party Transactions [Abstract] Change in fair value of equity investments Increase (Decrease) in Equity Securities, FV-NI Preferred stock, par value (in USD per share) Preferred Stock, Par or Stated Value Per Share Revenues From External Customers And Long Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] The ATM The ATM [Member] The ATM Total deferred revenue Revenue, Remaining Performance Obligation, Deferred Revenue Revenue, Remaining Performance Obligation, Deferred Revenue Summary of Weighted Average Valuation Assumptions Used for Options Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Lease costs Lease, Cost Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Cost of sales Cost of Sales [Member] Goodwill Goodwill Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Summary of Operating Leases Lease, Cost [Table Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Equity Components [Axis] Equity Components [Axis] Rest of World Non-US [Member] Unbilled and other receivables Increase Decrease In Unbilled And Other Receivables Increase decrease in unbilled and other receivables. Common Stock Unallocated Common Stocks [Member] Unallocated common stock. Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Number of reportable segments Number of Reportable Segments Valuation assumptions Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] Supplemental disclosure of cash flow and noncash information Supplemental Cash Flow Information [Abstract] Other Performance Measure, Amount Other Performance Measure, Amount Entity Address, State or Province Entity Address, State or Province Principal payments on finance leases Finance Lease, Principal Payments Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Related Party Related and Nonrelated Parties [Domain] Total current liabilities Liabilities, Current Net increase in cash and cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Change in fair value of equity investments Mark-to-market gain (loss) on equity investments Equity Securities, FV-NI, Gain (Loss) Individual: Individual [Axis] Drug discovery Drug Discovery [Member] Drug discovery. Vesting [Axis] Vesting [Axis] EMEA APAC [Member] APAC Research and development Research and Development Expense [Member] Additional paid-in capital Additional Paid in Capital, Common Stock Net cash provided by investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Revenue, remaining performance obligation, expected timing of satisfaction, period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Document Fiscal Year Focus Document Fiscal Year Focus Right of use assets - operating leases Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Entity Interactive Data Current Entity Interactive Data Current Deferred revenue, long-term: Deferred Revenue, Noncurrent [Abstract] Plan Name [Domain] Plan Name [Domain] Performance Based Restricted Stock Units Performance Based Restricted Stock Units [Member] Performance Based Restricted Stock Units Unrecognized compensation cost expected to be recognized over a weighted average period (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Issuances of common stock upon stock option exercises (in shares) Options, exercises in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Equity [Abstract] Equity [Abstract] Segment Reporting Segment Reporting Disclosure [Text Block] Disaggregation Of Revenue [Table] Disaggregation of Revenue [Table] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Denominator: Weighted Average Number Of Shares Outstanding Basic And Diluted [Abstract] Weighted average number of shares outstanding basic and diluted. Number of specified biological targets Contract With Customer, Number Of Specified Biological Targets Contract With Customer, Number Of Specified Biological Targets Software products and services Total software revenue Software Products And Services [Member] Software products and services. Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Depreciation and amortization Depreciation, Depletion and Amortization Other assets Other Assets, Noncurrent Customer Customer [Domain] Entity Central Index Key Entity Central Index Key PEO Name PEO Name Schedule Of Revenues From External Customers And Long Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Total revenues Total software revenue Total contribution revenue Revenues Consideration received on transaction Sale of Stock, Consideration Received on Transaction Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Arrangement Duration Trading Arrangement Duration Schedule Of Segment Reporting Information By Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Tranche One Share-Based Payment Arrangement, Tranche One [Member] Deferred revenue Contract with Customer, Liability, Current Segments Segments [Axis] Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Exercise Price Award Exercise Price Software contribution revenue recognition Software Contribution Revenue Recognized Software contribution revenue recognized. Entity Filer Category Entity Filer Category Local Phone Number Local Phone Number Class of Stock [Domain] Class of Stock [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Unrecognized compensation cost related to vested stock options granted Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Contract with customers, payment terms Contract With Customers Payment Terms Contract with customers, payment terms. Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Assets Assets [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Vesting [Domain] Vesting [Domain] Fair Value Measurements Fair Value Disclosures [Text Block] Stockholders' equity: Equity, Attributable to Parent [Abstract] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Award vesting rights (in percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Deferred revenue Deferred Revenue Research and development Research and development Research and Development Expense Accumulated other comprehensive income (loss) AOCI Attributable to Parent [Member] Investment, Name Investment, Name [Axis] Allowance for doubtful accounts receivable Accounts Receivable, Allowance for Credit Loss, Current Lease liabilities - operating leases, long-term Operating Lease, Liability, Noncurrent Eligible to vest (in shares) Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Eligible To Vest, Number Share-based Compensation Arrangement By Share-based Payment Award, Equity Instruments Other Than Options, Eligible To Vest, Number Fair Value as of Grant Date Award Grant Date Fair Value Entity Registrant Name Entity Registrant Name Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Stock granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Deferred revenue, short-term: Deferred Revenue, Current [Abstract] Number of units forfeited during period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Related Party Transaction [Line Items] Related Party Transaction [Line Items] Document Quarterly Report Document Quarterly Report Total Assets, Fair Value Disclosure Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Counterparty Name Counterparty Name [Domain] Non-marketable equity security Equity Securities without Readily Determinable Fair Value, Amount Stock split, conversion ratio Stockholders' Equity Note, Stock Split, Conversion Ratio Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Cash payments to purchase of shares Payments to Acquire Equity Securities, FV-NI Weighted average fair value of restricted stock units granted (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Related Party Related and Nonrelated Parties [Axis] Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Collaborative Arrangement and Arrangement Other than Collaborative Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Restatement Determination Date: Restatement Determination Date [Axis] Non-PEO NEO Non-PEO NEO [Member] Accounts Receivable Accounts Receivable [Member] Eligible Performance Based Restricted Stock Units Eligible Performance Based Restricted Stock Units [Member] Eligible Performance Based Restricted Stock Units Drug Discovery Drug Discovery Segment [Member] Drug Discovery Segment. Sale of Stock Sale of Stock [Axis] Name Trading Arrangement, Individual Name All Award Types Award Type [Domain] Deferred income Deferred Income Equity Awards Adjustments Equity Awards Adjustments [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] BMS Bristol Myers Squibb [Member] Bristol-Myers Squibb. Disaggregation Of Revenue [Line Items] Disaggregation of Revenue [Line Items] Compensation Amount Outstanding Recovery Compensation Amount Contract Assets Contract Assets [Member] Contract Assets Expected dividend yield (in percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Deferred revenue, revenue recognized Contract with Customer, Liability, Revenue Recognized Accrued payroll, taxes, and benefits Increase (Decrease) in Employee Related Liabilities 2028 Lessee, Operating And Finance Lease, Liability, To Be Paid, Year Two Lessee, Operating And Finance Lease, Liability, To Be Paid, Year Two MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Revenues: Revenues [Abstract] Unbilled and other receivables, net of allowance for unbilled receivables of $140 and $140 Unbilled And Other Receivables Current Unbilled and other receivables current. 2020 Plan Twenty Twenty Stock Plan [Member] Twenty twenty stock plan. Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Accumulated other comprehensive (loss) income Accumulated Other Comprehensive Income (Loss), Net of Tax Sales and marketing Sales and marketing Selling and Marketing Expense Financial Instruments [Domain] Financial Instruments [Domain] 2027 Lessee, Operating And Finance Lease, Liability, To Be Paid, Year One Lessee, Operating And Finance Lease, Liability, To Be Paid, Year One Present value of future minimum lease payments Operating And Finance Lease, Liability Operating And Finance Lease, Liability Segments Segments [Domain] Income Statement Location Statement of Income Location, Balance [Axis] Award Date [Domain] Award Date [Domain] APAC EMEA [Member] Hosted software Hosted Software [Member] Hosted software. Equity Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Allowance for unbilled receivable Allowance For Unbilled Receivables Current Allowance for unbilled receivables current. Achievement percent Share-Based Compensation Arrangement By Share-Based Payment Award, Achievement Percent Share-Based Compensation Arrangement by Share-Based Payment Award, Achievement Percent Schedule of Timing of Revenue Recognition Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Software contribution revenue recognition amount Software Contribution Revenue Recognition Amount Software contribution revenue recognition amount. Minimum Minimum [Member] Net Loss per Share Attributable to Common and Limited Common Stockholders Earnings Per Share, Policy [Policy Text Block] Cost of revenues: Segment cost of revenues Cost of Revenue [Abstract] Company Selected Measure Name Company Selected Measure Name Voting Common Stock Voting Common Stock [Member] Voting common stock. Preferred stock, $0.01 par value. Authorized 10,000,000 shares; zero shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively Preferred Stock, Value, Issued Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] All Executive Categories All Executive Categories [Member] Common stock Common Stock, Value, Issued Less: current portion of lease payments Operating And Finance Lease, Liability, Current Operating And Finance Lease, Liability, Current Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Tranche Two Share-Based Payment Arrangement, Tranche Two [Member] Number of performance obligations Number Of Performance Obligations Number Of Performance Obligations Weighted average shares used to compute net loss per share of common and limited common stockholders, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Commitments and contingencies (Note 5) Commitments and Contingencies Fair value of shares vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Increase (decrease) in liabilities: Increase (Decrease) in Operating Liabilities [Abstract] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Entity Small Business Entity Small Business Sales and marketing Selling and Marketing Expense [Member] Schedule of Revenues by Geographic Area Revenue from External Customers by Geographic Areas [Table Text Block] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Document Transition Report Document Transition Report Equity Investments Equity Method Investments [Policy Text Block] Number of preferred shares purchased (in shares) Number Of Preferred Shares Purchased Number of preferred shares purchased. Underlying Securities Award Underlying Securities Amount Equity Component [Domain] Equity Component [Domain] Cash paid for leases Operating And Finance Lease, Payments Operating And Finance Lease, Payments Document Period End Date Document Period End Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Income Taxes Income Tax Disclosure [Text Block] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Total backlog Revenue, Remaining Performance Obligation, Backlog Revenue, Remaining Performance Obligation, Backlog Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Document Type Document Type Structure Therapeutics Structure Therapeutics [Member] Structure therapeutics. Equity investments Equity Method Investments, Fair Value Disclosure Level 3 Fair Value, Inputs, Level 3 [Member] July 2024 Agreement with Bill & Melinda Gates Foundation July 2024 Agreement With Bill & Melinda Gates Foundation [Member] July 2024 Agreement With Gates Ventures Limited Liability Company Net Loss per Share Attributable to Common and Limited Common Stockholders Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Product and Service [Axis] Product and Service [Axis] Contribution Contribution Contribution [Member] Total revenues Total segment revenues Revenue from Contract with Customer, Excluding Assessed Tax All Individuals All Individuals [Member] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Software contribution Drug Discovery Services [Member] Drug discovery member. Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Point in Time Transferred at Point in Time [Member] Name Forgone Recovery, Individual Name Options granted, contractual term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Unallocated (expense) income: Unallocated [Abstract] Unallocated. Proceeds from issuances of common stock upon stock option exercises Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Closing price of common stock Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Intrinsic value of options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Marketable securities Marketable Securities, Current Discovery and development milestones to be received Revenue, Remaining Performance Obligation, Variable Consideration, Research, Development and Regulatory Milestones, Amount Revenue, Remaining Performance Obligation, Variable Consideration, Research, Development and Regulatory Milestones, Amount Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Commercial milestones to be received Revenue, Remaining Performance Obligation, Variable Consideration, Commercial Milestones, Amount Revenue, Remaining Performance Obligation, Variable Consideration, Commercial Milestones, Amount Current liabilities: Liabilities, Current [Abstract] Geographical Geographical [Axis] Ajax Therapeutics, Inc Ajax Therapeutics Inc [Member] Ajax Therapeutics, Inc. Total operating expenses Operating Expenses Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Level 1 Fair Value, Inputs, Level 1 [Member] Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Employee Service Share Based Compensation Allocation of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Cash, cash equivalents, restricted cash, and marketable securities Cash, Cash Equivalents, Restricted Cash, And Marketable Securities, Current Cash, Cash Equivalents, Restricted Cash, And Marketable Securities, Current Schedule Of Related Party Transactions By Related Party [Table] Related Party Transaction [Table] Net loss per share of common and limited common stockholders, diluted (in USD per share) Earnings Per Share, Diluted Other accrued liabilities Increase (Decrease) in Other Accrued Liabilities Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Accounts receivable, net of allowance for doubtful accounts of $440 and $440 (includes related party amounts of $0 and $100, respectively) Net receivables Accounts Receivable, after Allowance for Credit Loss, Current Concentration Risk Benchmark Concentration Risk Benchmark [Domain] Title of 12(b) Security Title of 12(b) Security Supplemental disclosure of non-cash investing and financing activities Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Accrued payroll, taxes, and benefits Accrued Payroll Taxes, Current Shares issued (in shares) Sale of Stock, Number of Shares Issued in Transaction Earnings Per Share [Abstract] Earnings Per Share [Abstract] Description of Business Business Description and Basis of Presentation [Text Block] Total other expense Nonoperating Income (Expense) Investments, Debt and Equity Securities [Abstract] Gross profit Total segment gross profit Gross Profit Schedule of Potentially Dilutive Securities not Included in Diluted Per Share Calculations Anti-dilutive Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Deferred revenue Increase (Decrease) in Contract with Customer, Liability Percentage of voting securities Percentage Of Voting Securities Percentage of voting securities. Nimbus Therapeutics, LLC Nimbus Therapeutics L L C [Member] Nimbus Therapeutics LLC. Proceeds from disposal of shares Proceeds from Sale of Equity Securities, FV-NI Cash paid for income taxes Income Taxes Paid, Net Award Timing Disclosures [Line Items] Unrealized loss on marketable securities Unrealized loss on marketable securities OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Thereafter Lessee, Operating And Finance Lease, Liability, To Be Paid, After Year Four Lessee operating lease liability payments due after year four. Property and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Stockholders' Equity Equity [Text Block] Net loss Net loss Net loss attributable to Schrödinger common and limited common stockholders Net Income (Loss) Attributable to Parent Expiration Date Trading Arrangement Expiration Date Less: imputed interest Lessee, Operating And Finance Lease, Liability, Undiscounted Excess Amount Lessee, Operating And Finance Lease, Liability, Undiscounted Excess Amount Other accrued liabilities Other Accrued Liabilities, Current Lease term Finance And Operating Lease, Weighted Average Remaining Lease Term Finance And Operating Lease, Weighted Average Remaining Lease Term Related party transactions amount Related Party Transaction, Amounts of Transaction Award vesting period (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Timing of Transfer of Good or Service [Axis] Timing of Transfer of Good or Service [Axis] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Software contribution Revenue Not from Contract with Customer Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Numerator: Net Income (Loss) Attributable to Parent [Abstract] Adoption Date Trading Arrangement Adoption Date Reclassifications of Prior Year Presentation Reclassification, Comparability Adjustment [Policy Text Block] Expected to be recognized over a weighted average period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Accounts receivable, net (includes related party amounts of $100 and $0, respectively) Accounts receivable, net Increase (Decrease) in Accounts Receivable Contract assets Contract with Customer, Asset, after Allowance for Credit Loss Significant Accounting Policies [Table] Significant Accounting Policies [Table] Significant accounting policies. Entity Current Reporting Status Entity Current Reporting Status Customer Customer [Axis] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Loss from operations Operating Income (Loss) Number of shares available to issue in transaction Sale of Stock, Remaining Value Of Shares Available For Issuance Sale of Stock, Remaining Value Of Shares Available For Issuance Accumulated deficit Retained Earnings (Accumulated Deficit) Research, Collaboration and License Agreement Research, Collaboration and License Agreement [Member] Research, Collaboration and License Agreement Loss on disposal of property and equipment Gain (Loss) on Disposition of Property Plant Equipment Financial Instrument [Axis] Financial Instrument [Axis] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Over Time Transferred over Time [Member] Software contribution Software Contribution [Member] Software contribution. Purchases of property and equipment in accrued liabilities Noncash or Part Noncash Acquisition, Fixed Assets Acquired Software Software Segment [Member] Software Segment. Current Fiscal Year End Date Current Fiscal Year End Date Class of Stock [Axis] Class of Stock [Axis] Expected term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Number of shares per award Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Award Conversion Upon Achievement, Number Of Shares Per Award Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Award Conversion Upon Achievement, Number Of Shares Per Award Number of shares available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Other income Other Nonoperating Income (Expense) Statement [Table] Statement [Table] Adjustments to reconcile net loss to net cash (used in) provided by operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Weighted average fair value of options granted (in USD per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Revenue Benchmark Revenue Benchmark [Member] Series C Preferred Stock Series C Preferred Stock [Member] Deferred revenue Contract with Customer, Liability Schedule of Assets and Liabilities Measured at Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Proceeds from maturity of marketable securities Proceeds from Sale and Maturity of Marketable Securities Marketable securities Equity Securities, FV-NI, Current Timing of Transfer of Good or Service [Domain] Timing of Transfer of Good or Service [Domain] Unrecognized tax benefits Unrecognized Tax Benefits Total shares subject to outstanding common stock options and unvested RSUs and PRSUs (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Professional services Professional Services [Member] Professional services. All Adjustments to Compensation All Adjustments to Compensation [Member] Fair Value By Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Amendment Flag Amendment Flag Segment gross profit: Gross Profit [Abstract] Termination Date Trading Arrangement Termination Date Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Milestone payment yet to be achieved Milestone Payment Yet To Be Achieved Milestone payment yet to be achieved. Tranche Three Share-Based Payment Arrangement, Tranche Three [Member] Remainder of 2026 Lessee, Operating And Finance Lease, Liability, to be Paid, Remainder of Fiscal Year Lessee, Operating And Finance Lease, Liability, to be Paid, Remainder of Fiscal Year Receivable, after allowance for credit loss, current Contract with Customer, Receivable, after Allowance for Credit Loss, Current Issuance of common stock upon vesting of RSUs and PRSUs Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Weighted average shares used to compute net loss per share of common and limited common stockholders, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Schedule of Basic and Diluted Net (Loss) Income Per Share Attributable to Common and Limited Stockholders Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Director Director [Member] Subsequent Events [Abstract] Segment Reporting [Abstract] Segment Reporting [Abstract] Changes in market value of investments, net of tax: OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax [Abstract] Total cost of revenues Total segment cost of revenues Cost of Revenue Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Risk-free interest rate (in percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Other (expense) income: Nonoperating Income (Expense) [Abstract] Entity Tax Identification Number Entity Tax Identification Number Proceeds from disposition and sale of equity investments, net Proceeds from Sale of Equity Method Investments Columbia University and Richard Friesner Columbia University and Richard Friesner [Member] Columbia University and Richard Friesner Customer C Customer C [Member] Customer C Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Common stock, par value (in USD per share) Common Stock, Par or Stated Value Per Share Basis of Presentation and Use of Estimates Basis Of Presentation And Use Of Estimates Policy [Policy Text Block] Basis of presentation and use of estimates. Common stock, shares issued (in shares) Common Stock, Shares, Issued Timing of revenue recognition Timing Of Revenue Recognition Percentage Timing of revenue recognition, percentage. Lease liabilities, long-term Operating And Finance Lease, Liability, Noncurrent Operating And Finance Lease, Liability, Noncurrent Grant of common stock (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Subsequent Events Subsequent Events [Text Block] Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name 2029 Lessee, Operating And Finance Lease, Liability, To Be Paid, Year Three Lessee, Operating And Finance Lease, Liability, To Be Paid, Year Three Total liabilities Liabilities Antidilutive Securities, Name Antidilutive Securities, Name [Domain] Total milestones to be received from initial programs Revenue, Remaining Performance Obligation, Variable Consideration Amount Revenue, Remaining Performance Obligation, Variable Consideration Amount Purchases of property and equipment in accounts payable Capital Expenditures Incurred but Not yet Paid Reduction in the carrying amount of right of use assets - operating leases Increase Decrease In Reduction In The Carrying Amount Of Right Of Use Assets, Operating Increase (decrease) in reduction in the carrying amount of right of use assets. Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Operating expenses: Operating Expenses [Abstract] Prepaid expenses Prepaid Expense, Current Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] 2030 Lessee, Operating And Finance Lease, Liability, To Be Paid, Year Four Lessee, Operating And Finance Lease, Liability, To Be Paid, Year Four Statement [Line Items] Statement [Line Items] Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalent 2010 Plan Two Thousand Ten Stock Plan [Member] Two thousand ten stock plan. Counterparty Name Counterparty Name [Axis] Customer A Customer A [Member] Customer A. Common stock Common Stock [Member] Number of units vested during period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Marketable securities Debt Securities, Available-for-Sale Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member]